I agree that this site is using cookies. You can find further informations here.
X
Fredrik Schjesvold
219  results:
Search for persons X
?
1

Neoplastic plasma cells with Auer rod‐like inclusions:

Jakob, Nordberg Nørgaard ; Frida, Bugge Askeland ; Geir, Tjønnfjord.
eJHaem.  1 (2020)  1 - p. 6-7 , 2020
Link: https://doi.org/10.1002/..
 
?
2

Isatuximab-pomalidomide-dexamethasone versus pomalidomide-d..:

Richardson, Paul G. ; Perrot, Aurore ; Miguel, Jesus San...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
3

In multiple myeloma, monthly treatment with zoledronic acid..:

Lund, Thomas ; Gundesen, Michael Tveden ; Juul Vangsted, Annette...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
4

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment w..:

Partanen, Anu ; Waage, Anders ; Peceliunas, Valdas...
Cancers.  16 (2024)  5 - p. 1024 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Consensus guidelines and recommendations for the management..:

Lin, Yi ; Qiu, Lugui ; Usmani, Saad...
The Lancet Oncology.  25 (2024)  8 - p. e374-e387 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide..:

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  3 - p. 165-176.e4 , 2024
Link: https://doi.org/10.1016/..
 
?
7

VRD versus VCD as induction therapy before autologous stem ..:

Nørgaard, Jakob Nordberg ; Moore, Kari Lenita Falck ; Slørdahl, Tobias S....
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Health-related quality of life and quality-adjusted progres..:

Nielsen, Lene Kongsgaard ; Schjesvold, Fredrik ; Möller, Sören...
Journal of Patient-Reported Outcomes.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
9

P1671: CARFILZOMIB-DEXAMETHASONE MAINTENANCE HAMPERS RECOVE..:

Nielsen, Lene Kongsgaard ; Schjesvold, Fredrik ; Möller, Sören...
HemaSphere.  7 (2023)  S3 - p. e0377892 , 2023
Link: https://doi.org/10.1097/..
 
?
10

P-082 Will survival improve by treating multiple myeloma pa..:

Rasmussen, Anne-Marie ; Askeland, Frida ; Lysen, Anna...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S79-S80 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Intensifying treatment in PET-positive multiple myeloma pat..:

Nørgaard, Jakob Nordberg ; Abildgaard, Niels ; Lysén, Anna...
Leukemia.  37 (2023)  10 - p. 2107-2114 , 2023
Link: https://doi.org/10.1038/..
 
?
12

P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATIO..:

Callander, Natalie ; Richardson, Paul ; Hus, Marek...
HemaSphere.  7 (2023)  S3 - p. e9722122 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Phase I Study of Safety and Pharmacokinetics of RO7297089, ..:

Plesner, Torben ; Harrison, Simon J. ; Quach, Hang...
Clinical Hematology International.  5 (2023)  1 - p. 43-51 , 2023
Link: https://doi.org/10.1007/..
 
?
14

P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUA..:

Silvennoinen, Raija ; Partanen, Anu ; Waage, Anders...
HemaSphere.  7 (2023)  S3 - p. e5534069 , 2023
Link: https://doi.org/10.1097/..
 
?
15

P875: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE ..:

Bugge Askeland, Frida ; Haukås, Einar ; Slørdahl, Tobias S....
HemaSphere.  7 (2023)  S3 - p. e32161f4 , 2023
Link: https://doi.org/10.1097/..
 
1-15